Zobrazeno 1 - 10 of 63 pro vyhledávání: '"Perrin Ross A"'
1
Akademický článek
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX® Pregnancy Exposure Registry
Autor: Bianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, Kurt White, Avni Pandhi, Andres Greco, Achint Kumar, Nicholas Everage, Megan Vignos
Publikováno v: Drugs - Real World Outcomes, Vol 10, Iss 4, Pp 503-511 (2023)
Abstract Background and Objectives There is a lack of well-controlled US studies of intramuscular (IM) interferon beta (IFNβ)-1a use in pregnant women with multiple sclerosis; however, in the European Medicines Agency region, IFNβ formulations may
Externí odkaz: https://doaj.org/article/c4a61d7c7dfa47a1976981b1d5e0ba6e
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
Autor: Amy Perrin Ross, Christian Besser, Shubhanvita Naval, Dee Stoneman, Harriet Gaunt, Noreen Barker
Publikováno v: BMC Neurology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Sensoready® autoinjector pen facilitates self-administration of subcutaneous ofatumumab injections at home. We aim to investigate patient and nurse preference for using Sensoready® versus comparator autoinjectors in multiple scl
Externí odkaz: https://doaj.org/article/09f9c4180e394bd3b820367dd1e9138d
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study
Autor: Amy Perrin Ross, Alona Williamson, Jennifer Smrtka, Tracy Flemming Tracy, Carol Saunders, Constance Easterling, John Niewoehner, Nicole Mutschler
Publikováno v: Multiple Sclerosis International, Vol 2013 (2013)
There is need for a brief but comprehensive objective assessment tool to help clinicians evaluate relapse symptoms in patients with multiple sclerosis (MS) and their impact on daily functioning, as well as response to treatment. The 2-part Assessing
Externí odkaz: https://doaj.org/article/4f61ef32abf646ef94c1569e2411b8b9
Zobrazit plný text záznamu
8
Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis
Autor: Regine Buffels, M. Garas, Robert A. Bermel, H.-P. Hartung, K. Kadner, Rana Karabudak, Bruno Brochet, Thomas Berger, A. Perrin Ross, William M. Carroll, Joep Killestein, Marianna Manfrini, C. Nos, Ludo Vanopdenbosch, Francesco Patti, Trygve Holmøy, Mark S. Freedman, Timothy Vollmer, Qing Wang
Publikováno v: Hartung, H P, Berger, T, Bermel, R A, Brochet, B, Carroll, W M, Holmøy, T, Karabudak, R, Killestein, J, Nos, C, Patti, F, Ross, A P, Vanopdenbosch, L, Vollmer, T, Buffels, R, Garas, M, Kadner, K, Manfrini, M, Wang, Q & Freedman, M S 2020, ' Shorter infusion time of ocrelizumab : Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis ', Multiple Sclerosis and Related Disorders, vol. 46, 102492 . https://doi.org/10.1016/j.msard.2020.102492
Multiple Sclerosis and Related Disorders, 46:102492. Elsevier
Multiple Sclerosis and Related Disorders
Highlights • Infusion-related reaction rates were similar in shorter and conventional infusions • The majority of infusion-related reactions were mild to moderate • No infusion-related reactions were serious, life-threatening or fatal • No ne
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f162aa5bf211749cf649687168808c
https://doi.org/10.1016/j.msard.2020.102492
Zobrazit plný text záznamu
9
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database
Autor: Orit Neudorfer, Bianca Weinstock-Guttman, Judith Haas, Peleg Baruch, Amy Perrin Ross, Guillermo Izquierdo, Augusto Grinspan, Patricia K. Coyle, Claire S Riley, Talya Drillman, Magnhild Sandberg-Wollheim
Publikováno v: International journal of MS care. 20(1)
Background: Appropriate counseling and treatment for women with multiple sclerosis (MS) who may become pregnant requires an understanding of the effects of exposure to disease-modifying therapies (DMTs) during pregnancy. Current reports and studies a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::488c682343a77dfa759d63989c77af5a
https://pubmed.ncbi.nlm.nih.gov/29507538
Zobrazit plný text záznamu
10
Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
Autor: Tjalf Ziemssen, Amy Perrin Ross, Mark Rametta, Lauren Sylvester
Publikováno v: Neurology and Therapy
Introduction Multiple sclerosis (MS) typically requires life-long management with disease-modifying therapies (DMTs). Many DMTs require regular self-injection, and can be associated with injection site reactions, pain, and needle/injection phobia—b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93440fd4c15c6149a57d45ed5a388ea
http://europepmc.org/articles/PMC4685867
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje